Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder = Le sulfate d'héparane, un anticoagulant circulant chez un malade présentant un syndrome hémorragique fatalPALMER, R. N; RICK, M. E; RICK, P. D et al.The New England journal of medicine. 1984, Vol 310, Num 26, pp 1696-1699, issn 0028-4793Article

How to use... lupus anticoagulantsSEN, Ethan S; BERESFORD, Michael W; AVCIN, Tadej et al.Archives of disease in childhood. Education and practice edition. 2013, Vol 98, Num 2, pp 52-57, issn 1743-0585, 6 p.Article

Anticoagulant circulant de type antiprothrombinase: étude rétrospective de 134 cas = Antiprothrombinase circulating anticoagulant, a retrospective study of 134 casesGOUAULT-HEILMANN, M; INTRATOR, L; SOBEL, A et al.Annales de médecine interne (Paris). 1987, Vol 138, Num 4, pp 251-255, issn 0003-410XArticle

A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemiaBUSSEL, J. B; STEINHERZ, P. G; MILLER, D. R et al.American journal of hematology. 1984, Vol 16, Num 1, pp 83-90, issn 0361-8609Article

Tests for lupus anticoagulant revisitedDERKSEN, Ronald H. W. M; DE GROOT, Philip G.Thrombosis research. 2004, Vol 114, Num 5-6, pp 521-526, issn 0049-3848, 6 p.Conference Paper

Les anticoagulants circulants pathologiques = Pathological circulating anticoagulantsGUERIN, V.Le Biologiste. 1988, Vol 22, Num 177, pp 289-294, issn 0981-6003Article

Acquired symptomatic inhibitors of plasma clotting factors in non hemophilic childrenRYAN, B. R; ARKEL, Y; WALTERS, T. R et al.The American journal of pediatric hematology/oncology. 1986, Vol 8, Num 2, pp 144-148, issn 0192-8562Article

Anticoagulant circulant de type lupique antiprothrombinase = Circulating lupus anticoagulant. AntiprothrombinaseGOUJARD, C; DELFRAISSY, J. F.Angéiologie (Paris). 1988, Vol 40, Num 8, issn 0003-3049, 251, 253-257 [6 p.]Article

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulantBOEY, M. L; COLACO, C. B; GHARAVI, A. E et al.British medical journal (1857). 1983, Vol 287, Num 6398, pp 1021-1023, issn 0007-1447Article

Correction of clotting factor deficiencies in plasma from patients with lupus-like anticoagulantsCLYNE, L. P; HONIG, C. L; DAINIAK, N et al.Thrombosis and haemostasis. 1984, Vol 51, Num 3, pp 317-320, issn 0340-6245Article

Anticoagulants circulants en dehors de l'hémophilie. Enquête multicentrique conduite par le secrétariat à la recherche de la SNFMI à propos de 207 observations = Circulating anticoagulants, haemophilia excluded. A multicentric stydy by the French National Society of internal medicine about 207 casesLE THI HUONG DU; GUILLEVIN, L; WIEDERKEHR, J. L et al.La Revue de médecine interne (Paris). 1988, Vol 9, Num 1, pp 33-39, issn 0248-8663Article

Significance of the lupus anticoagulantESPINOZA, L. R; HARTMANN, R. C.American journal of hematology. 1986, Vol 22, Num 3, pp 331-337, issn 0361-8609Article

Anticoagulants circulants et thromboses vasculaires = Circulating anticoagulant and vascular thrombosisGIRONNET, I; MEDINA, M; SERISE, J.-M et al.Bordeaux médical. 1984, Vol 17, Num 20, pp 1013-1016, issn 0021-7867Article

Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulantENGLERT, H. J; HAWKES, C. H; BOEY, M. L et al.British medical journal (1857). 1984, Vol 289, Num 6445, issn 0007-1447, 576Article

UN ANTICOAGULANT CIRCULANT INHIBITEUR DE LA PROTHROMBINASE: A PROPOS D'UNE OBSERVATIONWAGNER JEAN.1979; ; FRA; DA. 1979; 30; 81-(17) P.: ILL.; 30 CM; BIBL. 110 REF.; TH.: MED./GRENOBLE 1/1979Thesis

Further evidence of false negative screening for lupus anticoagulantsMOORE, G. W; HENLEY, A; GREENWOOD, C. K et al.Thrombosis research. 2008, Vol 121, Num 4, pp 477-484, issn 0049-3848, 8 p.Article

Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulantsMOORE, Gary W; SAVIDGE, Geoffrey F.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 3, pp 279-282, issn 0957-5235, 4 p.Article

Clinical manifestations and laboratory findings in patients with lupus anticoagulantsKORNBERG, A; SILBER, L; YONA, R et al.European journal of haematology. 1989, Vol 42, Num 1, pp 90-95, issn 0902-4441Article

THe laboratory diagnosis of lupus anticoagulantsLAZARCHICK, J; KIZER, J.Archives of pathology & laboratory medicine (1976). 1989, Vol 113, Num 2, pp 177-180, issn 0363-0153Article

The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cellsPETRAIUOLO, W; BOVILL, E; HOAK, J et al.Thrombosis research. 1988, Vol 50, Num 6, pp 847-855, issn 0049-3848Article

Thrombotic and hemorrhagic complications in children with the lupus anticoagulantBERNSTEIN, M. L; SALUSINSKY-STERNBACH, M; BELLEFLEUR, M et al.American journal of diseases of children (1960). 1984, Vol 138, Num 12, pp 1132-1135, issn 0002-922XArticle

Hémophilie acquise par anticorps antifacteur VIIIc. A propos de 3 observations = Acquired hemophilia: factor VIII antibodies. 3 case reportsWEILLIER, P.-J; JUHAN-VAGUE, I; GOLA, R et al.La Revue de médecine interne (Paris). 1983, Vol 4, Num 4, pp 323-326, issn 0248-8663Article

Les anticorps antiphospholipides = Antiphospholipid antibodiesFARI, A.La Revue Prescrire. 1995, Vol 15, Num 154, pp 608-610, issn 0247-7750Article

Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulantZANON, E; SARACINO, M. A; SIMIONI, P et al.Clinical and laboratory haematology. 1995, Vol 17, Num 3, pp 231-235, issn 0141-9854Conference Paper

Nécroses cutanées aux anticoagulants = Skin necrosis induced by anticoagulantCHOSIDOW, O; ROUJEAU, J. C; REVUZ, J et al.Gazette médicale de France (1969). 1990, Vol 97, Num 7, pp 61-63, issn 0016-5557Article